2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure …

W Mullens, A Auricchio, P Martens, K Witte… - EP …, 2021 - academic.oup.com
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure …

W Mullens, A Auricchio, P Martens… - European journal of …, 2020 - Wiley Online Library
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …

Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project

M Hadwiger, N Dagres, J Haug, M Wolf… - European heart …, 2022 - academic.oup.com
Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Improved prognosis after cardiac resynchronization therapy over a decade

F Leyva, A Zegard, P Patel, B Stegemann… - Europace, 2023 - academic.oup.com
Aims The past decade has seen an increased delivery of cardiac resynchronization therapy
(CRT) for patients with heart failure (HF). We explored whether clinical outcomes after CRT …

Time-trend treatment effect of cardiac resynchronization therapy with or without defibrillator on mortality: a systematic review and meta-analysis

B Veres, P Fehérvári, MA Engh, P Hegyi… - Europace, 2023 - academic.oup.com
Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

EHRA White Paper: knowledge gaps in arrhythmia management—status 2019

A Goette, A Auricchio, G Boriani, F Braunschweig… - EP …, 2019 - academic.oup.com
Clinicians accept that there are many unknowns when we make diagnostic and therapeutic
decisions. Acceptance of uncertainty is essential for the pursuit of the profession: bedside …

Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines

NC Edwards, AM Price, RP Steeds… - Nephrology Dialysis …, 2023 - academic.oup.com
The wide overlap between the syndromes of chronic kidney disease (CKD) and chronic
heart failure (HF) means that familiarity with the 2021 European Society of Cardiology …

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure

B Schrage, LH Lund, M Melin, L Benson, A Uijl… - EP …, 2022 - academic.oup.com
Aims Randomized data on the efficacy/safety of cardiac resynchronization therapy with vs.
without defibrillator (CRT-D,-P) in heart failure with reduced ejection fraction (HFrEF) are …

Left bundle branch area pacing versus biventricular pacing for cardiac resynchronization therapy on morbidity and mortality

Y Liang, Z Xiao, X Liu, J Wang, Z Yu, X Gong… - … Drugs and Therapy, 2022 - Springer
Background Left bundle branch area pacing (LBBAP) has emerged as an alternative to
biventricular pacing (BVP) for cardiac resynchronization therapy (CRT). We aimed to …